Carcinoembryonic Antigen Determination Reagent Kit (Chemiluminescent Immunoassay Method) - NMPA Registration 吉械注准20252400066
Access comprehensive regulatory information for Carcinoembryonic Antigen Determination Reagent Kit (Chemiluminescent Immunoassay Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 吉械注准20252400066 and owned by Dirui Industrial Co., Ltd.. The device was approved on January 24, 2025.
This page provides complete registration details including registrant information, province location (Jilin), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
用于体外定量检测人血清或血浆中癌胚抗原(CEA)的含量。主要用于对恶性肿瘤患者进行动态监测以辅助判断疾病进程或治疗效果,不能作为恶性肿瘤早期诊断或确诊依据,不用于普通人群的肿瘤筛查。
Reagent 1, Reagent 2, Reagent 3, Calibrator (high value, low value), Quality control (level 1, level 2). (Please refer to the manual for details)
试剂1、试剂2、试剂3、校准品(高值、低值)、质控品(水平1、水平2)。(具体内容详见说明书)

